ORMP
Oramed Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$3.41
+0.17 (+5.25%)
Analyst Consensus
Strong Sell
6 analysts
Price Target
Analyst Price Target
+180.1% upside
Low Target
$5.95
Average Target
$9.55
High Target
$10.69
Current Price
$3.41
Current
$3.41
$3.41
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69